Emory Stem Cell Core Becomes newest member of EICF

On September 11, 2017. the School of Medicine announced the opening of the new Emory Stem Cell Core (ESCC) as the newest member of the Emory Integrated Core Facilities (EICF). The ESCC brings a powerful new research platform in support of Emory investigators. This core’s focus and technical expertise will be to derive and characterize human induced pluripotent stem cells (iPSCs) from terminally differentiated somatic cells using non-integrating methods. Additionally, the core will provide training and educational resources to support investigators with interest in human stem cells. IPSCs generated from patients with a genetic defect allows for a unique opportunity to study the mechanisms of disease in an in vitro model. Other applications for these cells include developing a reporter line, drug screening and discovery, and potentially regenerative therapies. The core plans to interface with other members of the Emory Integrated Core Facilities as a pipeline to analyze patient cells that will inform drug discovery and personalized medicine.

The ESCC will be led by Megan Merritt, MS as the Core Director and is located in the Whitehead Building, room 429. Professor and Chair of Cell Biology, Gary Bassell, PhD will serve as the Scientific Director for the ESCC. 

Click here to link to Emory Integrated Core Facilities.